What's new

Human medicines European public assessment report (EPAR): Ulunar Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 23/04/2014, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Ulunar Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 23/04/2014, Revision: 15, Status: Authorised

Feb 17, 2025 - 17:13
 0
Human medicines European public assessment report (EPAR): Ulunar Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 23/04/2014, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Ulunar Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 23/04/2014, Revision: 15, Status: Authorised
Read More

Tags:

Previous Article

Dove lance un gel douche avec une étiquette qui détecte l'eau très chaude

Next Article

Minutes - HMA-EMA joint Big Data Steering Group teleconference - 11 December 2024

Related Posts

Clinical Trial Information System (CTIS) structured dat...

Mar 18, 2025  0

EMEA-003516-PIP01-23

EMEA-003516-PIP01-23

Apr 1, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0038/2024

Opinion/decision on a Paediatric investigation plan (PI...

Mar 25, 2025  0